Takara Bio (TSE:4974) Total Stockholders Equity : 円111,503 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Total Stockholders Equity?

Takara Bio's Total Stockholders Equity for the quarter that ended in Mar. 2024 was 円111,503 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Takara Bio's Book Value per Share for the quarter that ended in Mar. 2024 was 円925.98. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Takara Bio's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.01.

Takara Bio Total Stockholders Equity Historical Data

The historical data trend for Takara Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Total Stockholders Equity Chart

Takara Bio Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

66,494.00

74,180.00

95,871.00

112,217.00

111,503.00

Takara Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															112,217.00	107,954.00	111,854.00	112,240.00	111,503.00

Takara Bio (TSE:4974) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Takara Bio's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(111503	-	0)	/	120.416
	=	925.98

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Takara Bio's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(180	+	788)	/	111503
	=	0.01

Takara Bio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Takara Bio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Takara Bio (TSE:4974) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines